H.R. 4718: Drug Company Gift Disclosure Act
Before you vote › Federal bills
H.R. 4718: Drug Company Gift Disclosure Act
109th Congress · introduced 2006-02-08 · Health · Latest: Referred to the Subcommittee on Health.
federal
Follow this bill, step by step
- Where it came from: introduced 2006-02-08 · official record
- Who proposed it: Rep. DeFazio, Peter A. [D-OR-4] · what a sponsor is
- What happened next: no floor votes in our records yet. Why?
- Where it stands now: Referred to the Subcommittee on Health. Not final yet: this can still change. We check for updates every day.
- If it becomes law and spends money: follow the money to money laws, then agencies and contracts and grants.
Official title
Drug Company Gift Disclosure Act
Plain summary
Drug Company Gift Disclosure Act - Amends the Federal Food, Drug, and Cosmetic Act to require prescription drug manufacturers, packers, and distributors to annually disclose to the Commissioner of Food and Drugs the value, nature, and purpose of: (1) gifts made in connection with detailing, promotion, or other marketing activity to any physician, hospital, nursing home, pharmacist, health benefit plan administrator, or any other person authorized to prescribe or dispense prescription drugs; and (2) cash rebates, discounts, or any other financial consideration given to any pharmaceutical benefit manager in connection with such marketing activities. Defines "gift" as any gift, fee, payment, subsidy, or other economic benefit with a value of $50 or more, except free samples of prescription drugs and the payment of reasonable compensation and reimbursement of expenses in connection with a bona fide clinical trial. Requires the Commissioner to: (1) make such information available to the public; and (2) keep confidential any information related to a trade secret. Establishes civil penalties for violations.
Congressional Research Service summary (Introduced in House), quoted unchanged (nonpartisan). Read the source.
What a vote does
A “Yea” vote
If it passes both chambers and is signed, it becomes law.
A “Nay” vote
If it is not passed, current law stays as it is.
PSI Sci description of the legislative step (not an opinion).
What does this mean? (plain words)
Official text
Drug Company Gift Disclosure Act
Source: Congressional Research Service summary (Introduced in House)
AI explanation – may be wrong, check the official text
No AI explanation yet. It takes up to a minute to write and is then saved for everyone.
Limited to a few requests an hour per person.
The strongest published arguments
Arguments for (supporters)
Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.
Arguments against (opponents)
Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.
Alternatives
Needs sources: no published alternatives yet (for example a different bill, a law instead of an amendment, or keeping current law). We only show items backed by a published source. Suggest one.
How did my representative vote? · This bill's floor votes
Officials and money
Sponsor: Rep. DeFazio, Peter A. [D-OR-4] · 0 cosponsors
Cost estimate: No cost estimate published yet.
No linked floor roll calls in our collected records yet. This does not mean the bill has never had a vote. Check the official bill history.
Words on this page, explained (1)
- Authorization
- A law that creates or continues a government program and says what it may do, often with a suggested spending ceiling. An authorization alone does not provide money; a separate appropriation does.
Plain meanings written from linked sources. All words.
Sources
- Congressional Research Service summary (Introduced in House)
- Congress.gov
- Data: GovInfo BILLSTATUS bulk data (Library of Congress), BILLSTATUS-109hr4718.xml <https://www.govinfo.gov/bulkdata/BILLSTATUS/109/hr>
Record fed-us-cong109-hr4718 · catalog fed-us-congress-bills-cong109 · updated 2026-11-15 by psicol fed-bills-cong109